Top Markets
Coin of the day
SD BioSensor, Inc SD BioSensor, Inc

SD BioSensor, Inc

137310
Rang in aandelen #13253
SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced... SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.
Aandeelprijs
$4.23
Marktkapitalisatie
$506.22M
Verandering (1 dag)
-2.86%
Verandering (1 jaar)
-41.34%
Land
KR
Handel SD BioSensor, Inc (137310)

Categorie

Aandelsplitsingen voor SD BioSensor, Inc (137310)
Het aandeel SD BioSensor, Inc (symbool: 137310) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 31, 2026.
Eén aandeel 137310 dat vóór Aug 31, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 137310.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH